Prime presents at: Asembia - Prime Therapeutics LLC

The Promising Role of Novel Targeted Therapies in Addressing Clinical and Economic Burdens in DME

Event:

AXS23 Summit hosted by Asembia

Date/time:

May 2, 12:00 p.m.-1:30 p.m. Pacific

Prime participant:

YuQian Liu, Senior Director, Specialty Clinical Solutions, Magellan Rx

About Prime Therapeutics + Magellan Rx

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization serving health plans, employers and government programs. Prime is collectively owned by 19 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Magellan Rx Management LLC, a Prime Therapeutics LLC Company, is a pioneer in specialty and medical drug management and a leader in serving public sector state government programs. Together Prime and Magellan Rx provide a wide range of clients with solutions that bridge the distance between medical and pharmacy management. For more information visit primetherapeutics.com and magellanrx.com or follow us on X (Twitter) at @Prime_PBM and @Magellan_Rx.

Related news

Events

October 14, 2024

Prime presents at: AMCP Nexus 2024

Annual conference gathers 2,500+ managed care leaders to discuss complex health care issues.

Events

September 16, 2024

Prime presents: Specialty Summit 2024

From Sept. 16–18, 2024, the 21st annual event will connect, elevate and transform relationships, with exceptional speakers, insightful panels and in-person networking, helping to build the future of specialty.

Events

August 14, 2024

Prime presents at: Medicaid Enterprise Systems Conference (MESC) 2024

Educational session on Aug. 14 details the management of Medicaid pharmacy spend and maximizing technology to support state efforts.

View all news